Fig. 2: Updated PFS with Isa-Kd vs Kd (ITT population).
CI confidence interval, d dexamethasone, HR hazard ratio, Isa isatuximab, ITT intent to treat, K carfilzomib, mPFS median progression-free survival.
Fig. 2: Updated PFS with Isa-Kd vs Kd (ITT population). | Blood Cancer Journal
